Pharmacology

McGill Newsroom

McGill alumnus tagged to boost capacity and discovery in growing field

Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.

Classified as: Pharmacology, epidemiology, Pharmacoepidemiology, health and lifestyle, growing, Albert Boehringer, David Eidelman
Published on: 27 May 2016

By Chris Chipello, McGill Newsroom

Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain’s ability to process information with lightning speed, according to a new study.

Classified as: brain, Pharmacology, Derek Bowie, Alzheimer, neuron, Canadian Institutes of Health Research (CIHR), health and lifestyle, proteins, receptors, macromolecules, Philip Biggin
Published on: 25 Feb 2016

The discovery that tavilermide  induces the production of mucin, a crucial lubricant in tears, offers hope of relief to people who suffer from chronic dry eye disease. The invention and the development of a drug based on this small molecule was made by the team of Dr. H. Uri Saragovi, Senior Investigator at the Lady Davis Institute (LDI) at the Jewish General Hospital and Professor of Pharmacology at McGill University.

Classified as: Pharmacology, jewish general hospital, Lady Davis Institute (LDI), chronic dry eye disease, Saragovi, Allergan, Mimetogen
Published on: 3 Dec 2015

Researchers at McGill University have found that sodium – the main chemical component in table salt – is a unique “on/off” switch for a major neurotransmitter receptor in the brain. This receptor, known as the kainate receptor, is fundamental for normal brain function and is implicated in numerous diseases, such as epilepsy and neuropathic pain.

Classified as: brain, medicine, Pharmacology, sodium
Category:
Published on: 20 Aug 2013